The birth of therapy with cultured cells
Corresponding Author
Howard Green
Department of Cell Biology, Harvard Medical School, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115
Department of Cell Biology, Harvard Medical School, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115.Search for more papers by this authorCorresponding Author
Howard Green
Department of Cell Biology, Harvard Medical School, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115
Department of Cell Biology, Harvard Medical School, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115.Search for more papers by this authorAbstract
Long ago, I set out to solve a problem, but something happened along the way: I was diverted by an unexpected observation. Thereafter, the direction of my research was guided at each stage by increasing familiarity with the experimental material and what could be done with it. The result was the birth of therapy with cultured keratinocytes. Subsequent developments soon led to the formation of the company Biosurface Technology (later taken over by the Genzyme Corporation), which provided autologous cultures for burn victims in many parts of the world. Further progress by others led to new therapeutic applications of cultured keratinocytes, such as treatment of an ocular disease and gene therapy. Unfortunately, there have developed serious regulatory problems that are a danger to future progress. As described in this brief history, the initial stages of development of cell therapy for the treatment of human disease were possible only because there was no restraint by committees or governmental regulations. BioEssays 30:897–903, 2008. © 2008 Wiley Periodicals, Inc.
References
- 1 Stevens LC. 1970. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol 21: 364–382.
- 2 Todaro G, Green H. 1963. Quantitative studies of the growth of mouse embyro cells in culture and their development into established lines. J Cell Biol 17: 299–313.
- 3 Green H, Rheinwald JG, Sun TT. 1977. Properties of an epithelial cell type in culture: the epidermal keratinocyte and its dependence on products of the fibroblast. In: JP Revel, U Henning, CF Fox, editors. Cell Shape and Surface Architecture. NY: Alan R. Liss, Inc. p 493–500.
- 4 Rheinwald JG, Green H. 1975. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 6: 317–330.
- 5 Rheinwald JG, Green H. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6: 331–343.
- 6 Allen-Hoffmann BL, Rheinwald JG. 1984. Polycyclic aromatic hydrocarbon mutagenesis of human epidermal keratinocytes in culture. Proc Natl Acad Sci USA 81: 7802–7806.
- 7 Green H. 1978. Cyclic AMP in relation to proliferation of the epidermal cell: a new view. Cell 15: 801–811.
- 8 Peehl DM, Ham RG. 1980. Clonal growth of human keratinocytes with small amounts of dialyzed serum. In Vitro 16: 526–540.
- 9 Rheinwald JG, Green H. 1977. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265: 421–424.
- 10 Simon M, Green H. 1985. Enzymatic cross-linking of involucrin and other proteins by keratinocyte particulates in vitro. Cell 40: 677–683.
- 11 Wu YJ, Parker LM, Binder NE, Beckett MA, Sinard JH, et al. 1982. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 31: 693–703.
- 12 Green H, Kehinde O, Thomas J. 1979. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 76: 5665–5668.
- 13 Banks-Schlegel S, Green H. 1980. Formation of epidermis by serially cultivated human epidermal cells transplanted as an epithelium to athymic mice. Transplantation 29: 308–313.
- 14 Rice RH, Green H. 1979. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18: 681–694.
- 15 Watt FM, Green H. 1981. Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol 90: 738–742.
- 16 O'Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H. 1981. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1: 75–78.
- 17 Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H. 1984. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311: 448–451.
- 18 Compton CC, Gill JM, Bradford DA, Regauer S, Gallico GG, O'Connor NE. 1989. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. A light, electron microscopic and immunohistochemical study. Lab Invest 60: 600–612.
- 19 Green H. 1989. Regeneration of the skin after grafting of epidermal cultures [editorial]. Lab Invest 60: 583–584.
- 20 Rochat A, Barrandon Y. 2006. Regeneration of Epidermis from Adult Keratinocyte Stem Cells. In: R Lanza, J Gearhart, B Hogan, D Melton, R Pedersen, ED Thomas, J Thomson, M West, editors. Essentials of Stem Cell Biology. Boston: Elsevier Academic Press. p 439–447.
- 21 Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y. 2000. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation 70: 1588–1598.
- 22 Rama P, Bonini S, Lambiase A, Golisano O, Paterna P, et al. 2001. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 72: 1478–1485.
- 23 Barrandon Y, Green H. 1987. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84: 2302–2306.
- 24 De Luca M, Pellegrini G, Green H. 2006. Regeneration of squamous epithelia from stem cells of cultured grafts. Regen Med 1: 45–57.
- 25 Schermer A, Galvin S, Sun TT. 1986. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 103: 49–62.
- 26 Kenyon KR, Tseng SC. 1989. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96: 709–722; discussion 722–723.
- 27 Lindberg K, Brown ME, Chaves HV, Kenyon KR, Rheinwald JG. 1993. In vitro propagation of human ocular surface epithelial cells for transplantation. Invest Ophthalmol Vis Sci 34: 2672–2679.
- 28 Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. 1997. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349: 990–993.
- 29 Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, et al. 2006. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12: 1397–1402.
- 30 Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. 1994. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889–895.
- 31 Yanaga H, Yanaga K, Imai K, Koga M, Soejima C, Ohmori K. 2006. Clinical application of cultured autologous human auricular chondrocytes with autologous serum for craniofacial or nasal augmentation and repair. Plast Reconstr Surg 117: 2019–2030; discussion 2031–2032.